Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 5 points (0.0%) at 15,100 as of Thursday, May 9, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,176 issues advancing vs. 1,742 declining with 136 unchanged. The Health Services industry currently sits down 0.21 versus the S&P 500, which is down 0.21. Top gainers within the industry include Mindray Medical International ( MR), up 2.3%, and Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.3%. On the negative front, top decliners within the industry include Orthofix International N.V ( OFIX), down 16.31, HCA Holdings ( HCA), down 1.43, DaVita HealthCare Partners ( DVA), down 1.24 and UnitedHealth Group ( UNH), down 1.22. TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today: 5. Edwards Life ( EW) is one of the companies pushing the Health Services industry higher today. As of noon trading, Edwards Life is up $1.13 (1.73) to $66.58 on average volume Thus far, 533,045 shares of Edwards Life exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $65.11-$66.60 after having opened the day at $65.43 as compared to the previous trading day's close of $65.45. Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.2 billion and is part of the health care sector. The company has a P/E ratio of 20.2, above the S&P 500 P/E ratio of 17.7. Shares are down 27.4% year to date as of the close of trading on Wednesday. Currently there are 8 analysts that rate Edwards Life a buy, 1 analyst rates it a sell, and 9 rate it a hold. TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Edwards Life Ratings Report now. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.